

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.80054231 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.34071080 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.13416948 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.12901765 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.88049900 |
| 6 | vocalization behavior (GO:0071625) | 4.85486063 |
| 7 | glutamate secretion (GO:0014047) | 4.82446781 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.81058649 |
| 9 | cerebellar granule cell differentiation (GO:0021707) | 4.72499194 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.66753883 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.50716129 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.42302867 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.41793674 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.33429721 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.23164893 |
| 16 | cellular potassium ion homeostasis (GO:0030007) | 4.20532917 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.20114397 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.13508393 |
| 19 | protein localization to synapse (GO:0035418) | 4.07745268 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.00789989 |
| 21 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.00273632 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 3.99253541 |
| 23 | proline transport (GO:0015824) | 3.96141557 |
| 24 | L-amino acid import (GO:0043092) | 3.95670417 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.88681508 |
| 26 | exploration behavior (GO:0035640) | 3.88279106 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87154715 |
| 28 | sodium ion export (GO:0071436) | 3.81094131 |
| 29 | regulation of synapse structural plasticity (GO:0051823) | 3.78323348 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.75743715 |
| 31 | activation of protein kinase A activity (GO:0034199) | 3.73862353 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 3.73255241 |
| 33 | glutamate receptor signaling pathway (GO:0007215) | 3.72997161 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.70535439 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.66961007 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.55722439 |
| 37 | long-term memory (GO:0007616) | 3.53984780 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.53955240 |
| 39 | membrane depolarization during action potential (GO:0086010) | 3.49379341 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.49193039 |
| 41 | cell communication by electrical coupling (GO:0010644) | 3.45130928 |
| 42 | amino acid import (GO:0043090) | 3.42704071 |
| 43 | neurotransmitter transport (GO:0006836) | 3.42125937 |
| 44 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.41451227 |
| 45 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.38359195 |
| 46 | dendritic spine morphogenesis (GO:0060997) | 3.37055701 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.36906046 |
| 48 | positive regulation of dendritic spine development (GO:0060999) | 3.35647538 |
| 49 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33839977 |
| 50 | regulation of synapse maturation (GO:0090128) | 3.28720406 |
| 51 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.25795248 |
| 52 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.23295432 |
| 53 | regulation of postsynaptic membrane potential (GO:0060078) | 3.22514388 |
| 54 | neuromuscular process controlling posture (GO:0050884) | 3.21734253 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.21565428 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.19128431 |
| 57 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.18056459 |
| 58 | regulation of synaptic plasticity (GO:0048167) | 3.17803158 |
| 59 | potassium ion import (GO:0010107) | 3.16214014 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15788362 |
| 61 | regulation of neurotransmitter levels (GO:0001505) | 3.14529374 |
| 62 | neuromuscular synaptic transmission (GO:0007274) | 3.13757423 |
| 63 | transmission of nerve impulse (GO:0019226) | 3.11772784 |
| 64 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.11568146 |
| 65 | postsynaptic membrane organization (GO:0001941) | 3.10980046 |
| 66 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.09346177 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.08658988 |
| 68 | detection of calcium ion (GO:0005513) | 3.08655589 |
| 69 | regulation of cell communication by electrical coupling (GO:0010649) | 3.08514559 |
| 70 | glycine transport (GO:0015816) | 3.07769243 |
| 71 | neuromuscular process controlling balance (GO:0050885) | 3.06229529 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.06008870 |
| 73 | dendrite morphogenesis (GO:0048813) | 3.05080709 |
| 74 | * neuron recognition (GO:0008038) | 3.04656286 |
| 75 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03638430 |
| 76 | cell differentiation in hindbrain (GO:0021533) | 3.02553758 |
| 77 | innervation (GO:0060384) | 3.01694960 |
| 78 | membrane depolarization (GO:0051899) | 3.01658485 |
| 79 | regulation of vesicle fusion (GO:0031338) | 3.00216233 |
| 80 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.00173277 |
| 81 | long-term synaptic potentiation (GO:0060291) | 2.99070088 |
| 82 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.98358443 |
| 83 | potassium ion homeostasis (GO:0055075) | 2.97602383 |
| 84 | vesicle transport along microtubule (GO:0047496) | 2.96665905 |
| 85 | regulation of dendritic spine development (GO:0060998) | 2.95099776 |
| 86 | synaptic vesicle endocytosis (GO:0048488) | 2.94143837 |
| 87 | regulation of neurotransmitter transport (GO:0051588) | 2.93714045 |
| 88 | cellular sodium ion homeostasis (GO:0006883) | 2.93028320 |
| 89 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.92732109 |
| 90 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.92648225 |
| 91 | membrane hyperpolarization (GO:0060081) | 2.89741599 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.89547697 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.89152149 |
| 94 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.88904512 |
| 95 | response to auditory stimulus (GO:0010996) | 2.87883041 |
| 96 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.86984293 |
| 97 | mating behavior (GO:0007617) | 2.86536382 |
| 98 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.85584093 |
| 99 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.85231494 |
| 100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.82867839 |
| 101 | synaptic transmission (GO:0007268) | 2.79649313 |
| 102 | presynaptic membrane assembly (GO:0097105) | 2.79563004 |
| 103 | prepulse inhibition (GO:0060134) | 2.79320763 |
| 104 | neuronal ion channel clustering (GO:0045161) | 2.79214764 |
| 105 | positive regulation of neurotransmitter transport (GO:0051590) | 2.78964354 |
| 106 | central nervous system myelination (GO:0022010) | 2.78886811 |
| 107 | axon ensheathment in central nervous system (GO:0032291) | 2.78886811 |
| 108 | positive regulation of potassium ion transport (GO:0043268) | 2.77973663 |
| 109 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.77739348 |
| 110 | chemosensory behavior (GO:0007635) | 2.75910404 |
| 111 | cell communication involved in cardiac conduction (GO:0086065) | 2.75874016 |
| 112 | auditory behavior (GO:0031223) | 2.75056565 |
| 113 | cerebellar Purkinje cell layer development (GO:0021680) | 2.73439347 |
| 114 | regulation of synaptic transmission (GO:0050804) | 2.72706860 |
| 115 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.71618841 |
| 116 | regulation of ARF protein signal transduction (GO:0032012) | 2.71587184 |
| 117 | * axonal fasciculation (GO:0007413) | 2.71170521 |
| 118 | positive regulation of synaptic transmission (GO:0050806) | 2.70895153 |
| 119 | suckling behavior (GO:0001967) | 2.70719911 |
| 120 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.66191904 |
| 121 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.66191904 |
| 122 | positive regulation of Rap GTPase activity (GO:0032854) | 2.65282620 |
| 123 | acidic amino acid transport (GO:0015800) | 2.65218933 |
| 124 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.64895969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.00047581 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.06545167 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99589355 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.97343940 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.85158473 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61065427 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61065427 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59703949 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54571833 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53320466 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.50380866 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49639438 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48676396 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47873971 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.47234349 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41782682 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38176781 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32590989 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19767618 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18233585 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16799821 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12382416 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05909245 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.03304559 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94258698 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85562928 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75869707 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74240888 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73125675 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69887194 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59988145 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.58365901 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57787870 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57706731 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53026539 |
| 36 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51809132 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49459340 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37873417 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36879005 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35054612 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35021447 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33174160 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32422257 |
| 44 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28325801 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26301961 |
| 46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24703399 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24702333 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22731177 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22553369 |
| 50 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22491805 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20534631 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20391758 |
| 53 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20344498 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19635953 |
| 55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19626729 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18899649 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18805129 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18684658 |
| 59 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18580335 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18239548 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18057036 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17975873 |
| 63 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17642415 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14678125 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13570025 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13220952 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13172785 |
| 68 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.11194009 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09772000 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09354108 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08680016 |
| 72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07883919 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07346842 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06388638 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05377381 |
| 76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05035778 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04709950 |
| 78 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04185138 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03595985 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03193529 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02866296 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02649889 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02285882 |
| 84 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02208904 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01815884 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01098301 |
| 87 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00380850 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99198882 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99157610 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98060172 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97843634 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97674489 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96722223 |
| 94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96594593 |
| 95 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.96594244 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95698688 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95579096 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95245805 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95228580 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95130355 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94584957 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94489418 |
| 103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93329124 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93169607 |
| 105 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92573076 |
| 106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92465959 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90842248 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90803976 |
| 109 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.90058097 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89859570 |
| 111 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.89722857 |
| 112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88860731 |
| 113 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88132815 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87654943 |
| 115 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87107422 |
| 116 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86212829 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85927136 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84902333 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83597497 |
| 120 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.82580689 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.82361747 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82361747 |
| 123 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81408666 |
| 124 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77619997 |
| 125 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77619997 |
| 126 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76955509 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76412691 |
| 128 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.75931083 |
| 129 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.75882104 |
| 130 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.74473259 |
| 131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74351615 |
| 132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74126411 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73987046 |
| 134 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.72875976 |
| 135 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.71106256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.92521651 |
| 2 | MP0003880_abnormal_central_pattern | 3.99152032 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.88971055 |
| 4 | MP0004270_analgesia | 3.68766278 |
| 5 | MP0009745_abnormal_behavioral_response | 3.17966800 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.02878402 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.02512225 |
| 8 | MP0002064_seizures | 2.96205050 |
| 9 | MP0009046_muscle_twitch | 2.84319888 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.67138405 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.60073093 |
| 12 | MP0002822_catalepsy | 2.57232286 |
| 13 | MP0002272_abnormal_nervous_system | 2.55991513 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.45296123 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.36447508 |
| 16 | MP0002736_abnormal_nociception_after | 2.35485841 |
| 17 | MP0001486_abnormal_startle_reflex | 2.34029333 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.27699955 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.27046530 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.17292596 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.07416488 |
| 22 | MP0004858_abnormal_nervous_system | 1.98272884 |
| 23 | MP0001970_abnormal_pain_threshold | 1.97779223 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.94752220 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.89653252 |
| 26 | MP0008569_lethality_at_weaning | 1.89555759 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.86178404 |
| 28 | MP0001984_abnormal_olfaction | 1.73582804 |
| 29 | MP0004885_abnormal_endolymph | 1.69362022 |
| 30 | MP0003329_amyloid_beta_deposits | 1.68430455 |
| 31 | MP0002184_abnormal_innervation | 1.67920664 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.66771427 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.64362258 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.63019878 |
| 35 | MP0004924_abnormal_behavior | 1.59439907 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.59439907 |
| 37 | MP0000751_myopathy | 1.59119804 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.57805134 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.56753652 |
| 40 | MP0003879_abnormal_hair_cell | 1.51797348 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.51433049 |
| 42 | MP0000778_abnormal_nervous_system | 1.47644862 |
| 43 | MP0000955_abnormal_spinal_cord | 1.44288687 |
| 44 | MP0000920_abnormal_myelination | 1.42948225 |
| 45 | MP0003633_abnormal_nervous_system | 1.40887386 |
| 46 | MP0003283_abnormal_digestive_organ | 1.37238279 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.35307812 |
| 48 | MP0004043_abnormal_pH_regulation | 1.32968456 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.31135483 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.28774271 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.24781755 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.23882149 |
| 53 | MP0003787_abnormal_imprinting | 1.17239409 |
| 54 | MP0004215_abnormal_myocardial_fiber | 1.16485882 |
| 55 | MP0003122_maternal_imprinting | 1.12584188 |
| 56 | MP0003631_nervous_system_phenotype | 1.08677994 |
| 57 | MP0004085_abnormal_heartbeat | 1.04261658 |
| 58 | MP0004142_abnormal_muscle_tone | 1.04087365 |
| 59 | MP0003123_paternal_imprinting | 1.03804408 |
| 60 | MP0005535_abnormal_body_temperature | 1.03709347 |
| 61 | MP0002229_neurodegeneration | 0.98622789 |
| 62 | MP0001905_abnormal_dopamine_level | 0.98428787 |
| 63 | MP0008961_abnormal_basal_metabolism | 0.98033280 |
| 64 | MP0008874_decreased_physiological_sensi | 0.96904413 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.96158993 |
| 66 | MP0002152_abnormal_brain_morphology | 0.93018352 |
| 67 | MP0004087_abnormal_muscle_fiber | 0.92611423 |
| 68 | MP0008872_abnormal_physiological_respon | 0.92181849 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 0.90205735 |
| 70 | MP0004233_abnormal_muscle_weight | 0.89420225 |
| 71 | MP0000759_abnormal_skeletal_muscle | 0.89413631 |
| 72 | MP0001529_abnormal_vocalization | 0.89119827 |
| 73 | MP0003137_abnormal_impulse_conducting | 0.88806246 |
| 74 | MP0004036_abnormal_muscle_relaxation | 0.85882604 |
| 75 | MP0004130_abnormal_muscle_cell | 0.85474575 |
| 76 | MP0000747_muscle_weakness | 0.84717342 |
| 77 | MP0002106_abnormal_muscle_physiology | 0.84459370 |
| 78 | MP0003646_muscle_fatigue | 0.83768102 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.83611273 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.82949312 |
| 81 | MP0003634_abnormal_glial_cell | 0.82100596 |
| 82 | MP0001177_atelectasis | 0.80617897 |
| 83 | MP0003690_abnormal_glial_cell | 0.79642442 |
| 84 | MP0004742_abnormal_vestibular_system | 0.79083433 |
| 85 | MP0003075_altered_response_to | 0.77453776 |
| 86 | MP0004484_altered_response_of | 0.76785236 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.76607156 |
| 88 | MP0001299_abnormal_eye_distance/ | 0.73071557 |
| 89 | MP0000749_muscle_degeneration | 0.72998769 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.72684694 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.72304140 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.72044020 |
| 93 | MP0000604_amyloidosis | 0.71414412 |
| 94 | MP0002090_abnormal_vision | 0.71300958 |
| 95 | MP0001188_hyperpigmentation | 0.70920273 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.70882669 |
| 97 | MP0004084_abnormal_cardiac_muscle | 0.70656649 |
| 98 | MP0005369_muscle_phenotype | 0.70634068 |
| 99 | MP0005620_abnormal_muscle_contractility | 0.69960633 |
| 100 | MP0005187_abnormal_penis_morphology | 0.68821603 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.68270974 |
| 102 | MP0003632_abnormal_nervous_system | 0.66809996 |
| 103 | MP0006072_abnormal_retinal_apoptosis | 0.66677740 |
| 104 | MP0004510_myositis | 0.66648966 |
| 105 | MP0002752_abnormal_somatic_nervous | 0.65530185 |
| 106 | MP0003878_abnormal_ear_physiology | 0.65423681 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.65423681 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 0.64733512 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.64629219 |
| 110 | MP0002234_abnormal_pharynx_morphology | 0.63764423 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.63543056 |
| 112 | MP0005499_abnormal_olfactory_system | 0.63543056 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.57374932 |
| 114 | MP0001943_abnormal_respiration | 0.56978183 |
| 115 | MP0010769_abnormal_survival | 0.56936362 |
| 116 | MP0008877_abnormal_DNA_methylation | 0.56660096 |
| 117 | MP0002269_muscular_atrophy | 0.56363397 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.55909630 |
| 119 | MP0003045_fibrosis | 0.53514341 |
| 120 | MP0010768_mortality/aging | 0.53343101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.29494126 |
| 2 | Myokymia (HP:0002411) | 5.92582923 |
| 3 | Focal seizures (HP:0007359) | 5.46383210 |
| 4 | Visual hallucinations (HP:0002367) | 5.07923030 |
| 5 | Atonic seizures (HP:0010819) | 4.80664904 |
| 6 | Febrile seizures (HP:0002373) | 4.34726267 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.30676637 |
| 8 | Absence seizures (HP:0002121) | 4.23787568 |
| 9 | Action tremor (HP:0002345) | 4.01720398 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 3.94216992 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.77593284 |
| 12 | Dialeptic seizures (HP:0011146) | 3.75191736 |
| 13 | Obstructive sleep apnea (HP:0002870) | 3.36748373 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.32795971 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 3.30798287 |
| 16 | Depression (HP:0000716) | 3.23968246 |
| 17 | Poor eye contact (HP:0000817) | 3.20174400 |
| 18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.19583804 |
| 19 | Nemaline bodies (HP:0003798) | 3.15101728 |
| 20 | Broad-based gait (HP:0002136) | 3.09825516 |
| 21 | Abnormal social behavior (HP:0012433) | 3.09513746 |
| 22 | Impaired social interactions (HP:0000735) | 3.09513746 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04039004 |
| 24 | Ankle clonus (HP:0011448) | 3.02586015 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 2.94822002 |
| 26 | Truncal ataxia (HP:0002078) | 2.91661306 |
| 27 | Postural instability (HP:0002172) | 2.91337463 |
| 28 | Anxiety (HP:0000739) | 2.90067179 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.88347436 |
| 30 | Pheochromocytoma (HP:0002666) | 2.88250206 |
| 31 | Hyperventilation (HP:0002883) | 2.87802520 |
| 32 | Ventricular fibrillation (HP:0001663) | 2.86075426 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 2.84609688 |
| 34 | Amblyopia (HP:0000646) | 2.77160934 |
| 35 | Dysmetria (HP:0001310) | 2.75318513 |
| 36 | Papilledema (HP:0001085) | 2.73578978 |
| 37 | Hemiplegia (HP:0002301) | 2.71077427 |
| 38 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.66104348 |
| 39 | Difficulty running (HP:0009046) | 2.65716926 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.65098926 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.64532136 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 2.61066895 |
| 43 | Muscle fiber splitting (HP:0003555) | 2.60780039 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.60017533 |
| 45 | Abnormality of the corticospinal tract (HP:0002492) | 2.57314169 |
| 46 | Subaortic stenosis (HP:0001682) | 2.54545536 |
| 47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.54545536 |
| 48 | EMG: myopathic abnormalities (HP:0003458) | 2.49123420 |
| 49 | Agitation (HP:0000713) | 2.48870016 |
| 50 | Insidious onset (HP:0003587) | 2.48397673 |
| 51 | Termporal pattern (HP:0011008) | 2.48397673 |
| 52 | Scanning speech (HP:0002168) | 2.46043555 |
| 53 | Status epilepticus (HP:0002133) | 2.45251708 |
| 54 | Impaired smooth pursuit (HP:0007772) | 2.43767040 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.42652763 |
| 56 | Neuroendocrine neoplasm (HP:0100634) | 2.41692869 |
| 57 | Akinesia (HP:0002304) | 2.40628085 |
| 58 | Tetraplegia (HP:0002445) | 2.39954830 |
| 59 | Urinary urgency (HP:0000012) | 2.37979250 |
| 60 | Dysmetric saccades (HP:0000641) | 2.36393571 |
| 61 | Exercise-induced myalgia (HP:0003738) | 2.36273021 |
| 62 | Lower limb amyotrophy (HP:0007210) | 2.35973390 |
| 63 | Drooling (HP:0002307) | 2.34904214 |
| 64 | Excessive salivation (HP:0003781) | 2.34904214 |
| 65 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34270384 |
| 66 | Hemiparesis (HP:0001269) | 2.33995142 |
| 67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.33248708 |
| 68 | EMG: neuropathic changes (HP:0003445) | 2.33067386 |
| 69 | Genetic anticipation (HP:0003743) | 2.31232832 |
| 70 | Bradykinesia (HP:0002067) | 2.30589294 |
| 71 | Torticollis (HP:0000473) | 2.28507563 |
| 72 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.28334363 |
| 73 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.28334363 |
| 74 | Intention tremor (HP:0002080) | 2.28050676 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.27367801 |
| 76 | Bundle branch block (HP:0011710) | 2.26116066 |
| 77 | Calf muscle hypertrophy (HP:0008981) | 2.26054783 |
| 78 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.24524827 |
| 79 | Exercise-induced muscle cramps (HP:0003710) | 2.23696274 |
| 80 | Hypsarrhythmia (HP:0002521) | 2.22488689 |
| 81 | Sleep apnea (HP:0010535) | 2.21383673 |
| 82 | Spastic gait (HP:0002064) | 2.21041088 |
| 83 | Cerebral hypomyelination (HP:0006808) | 2.20831243 |
| 84 | Stereotypic behavior (HP:0000733) | 2.19417215 |
| 85 | Heart block (HP:0012722) | 2.19401042 |
| 86 | Prolonged QT interval (HP:0001657) | 2.15665377 |
| 87 | Mutism (HP:0002300) | 2.15374788 |
| 88 | Focal dystonia (HP:0004373) | 2.14540507 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.13568060 |
| 90 | Abnormality of binocular vision (HP:0011514) | 2.13337488 |
| 91 | Diplopia (HP:0000651) | 2.13337488 |
| 92 | Abnormality of saccadic eye movements (HP:0000570) | 2.10875719 |
| 93 | Abnormal EKG (HP:0003115) | 2.09912783 |
| 94 | Progressive inability to walk (HP:0002505) | 2.09319618 |
| 95 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.05632435 |
| 96 | Increased circulating renin level (HP:0000848) | 2.05535549 |
| 97 | Megalencephaly (HP:0001355) | 2.05177714 |
| 98 | Clonus (HP:0002169) | 2.04833740 |
| 99 | Neurofibrillary tangles (HP:0002185) | 2.03701413 |
| 100 | Limb dystonia (HP:0002451) | 2.02909499 |
| 101 | Resting tremor (HP:0002322) | 1.99425199 |
| 102 | Delusions (HP:0000746) | 1.98841056 |
| 103 | Fetal akinesia sequence (HP:0001989) | 1.97210736 |
| 104 | Lower limb muscle weakness (HP:0007340) | 1.96752558 |
| 105 | Impaired vibratory sensation (HP:0002495) | 1.96393412 |
| 106 | Abnormal atrioventricular conduction (HP:0005150) | 1.96249159 |
| 107 | Foot dorsiflexor weakness (HP:0009027) | 1.95240568 |
| 108 | Abnormality of the calf musculature (HP:0001430) | 1.94671388 |
| 109 | Rapidly progressive (HP:0003678) | 1.94517290 |
| 110 | Sudden death (HP:0001699) | 1.93954605 |
| 111 | Turricephaly (HP:0000262) | 1.93021472 |
| 112 | Postural tremor (HP:0002174) | 1.92743460 |
| 113 | Abnormality of the foot musculature (HP:0001436) | 1.92304928 |
| 114 | Syncope (HP:0001279) | 1.92057752 |
| 115 | Slow saccadic eye movements (HP:0000514) | 1.91587131 |
| 116 | Absent speech (HP:0001344) | 1.90935421 |
| 117 | Craniofacial dystonia (HP:0012179) | 1.88779060 |
| 118 | Hypercortisolism (HP:0001578) | 1.88197666 |
| 119 | Insomnia (HP:0100785) | 1.87625715 |
| 120 | Blue irides (HP:0000635) | 1.87016140 |
| 121 | Central scotoma (HP:0000603) | 1.86690454 |
| 122 | Psychosis (HP:0000709) | 1.86288872 |
| 123 | Hypoventilation (HP:0002791) | 1.86142427 |
| 124 | Abnormality of pain sensation (HP:0010832) | 1.85475973 |
| 125 | Impaired pain sensation (HP:0007328) | 1.85475973 |
| 126 | Gait ataxia (HP:0002066) | 1.85142482 |
| 127 | Decreased circulating renin level (HP:0003351) | 1.84917197 |
| 128 | Annular pancreas (HP:0001734) | 1.84085443 |
| 129 | Myotonia (HP:0002486) | 1.80796797 |
| 130 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.78224396 |
| 131 | Spinal canal stenosis (HP:0003416) | 1.77413684 |
| 132 | Rigidity (HP:0002063) | 1.76814137 |
| 133 | Lower limb asymmetry (HP:0100559) | 1.76447828 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.75283591 |
| 135 | Incomplete penetrance (HP:0003829) | 1.75230980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.92762170 |
| 2 | EPHA4 | 3.68540854 |
| 3 | MAP3K9 | 3.52743944 |
| 4 | MAP3K4 | 3.10140525 |
| 5 | MINK1 | 2.48949869 |
| 6 | DAPK2 | 2.42595063 |
| 7 | MAP2K7 | 2.41256515 |
| 8 | KSR2 | 2.30733662 |
| 9 | MARK1 | 2.24598506 |
| 10 | PAK6 | 2.12583777 |
| 11 | MAP2K4 | 2.09941582 |
| 12 | NTRK1 | 2.09183163 |
| 13 | PRKD3 | 2.05509031 |
| 14 | OBSCN | 1.83612571 |
| 15 | CAMKK1 | 1.82141469 |
| 16 | MAP3K2 | 1.81016426 |
| 17 | NTRK2 | 1.77280187 |
| 18 | RIPK4 | 1.56816621 |
| 19 | PHKG2 | 1.50024667 |
| 20 | PHKG1 | 1.50024667 |
| 21 | CDK5 | 1.47923577 |
| 22 | GRK5 | 1.47344649 |
| 23 | CASK | 1.44932828 |
| 24 | LMTK2 | 1.41497766 |
| 25 | KSR1 | 1.40103794 |
| 26 | STK38 | 1.39485048 |
| 27 | MAPK12 | 1.33918883 |
| 28 | PRPF4B | 1.28107750 |
| 29 | MAP3K12 | 1.24478049 |
| 30 | DAPK1 | 1.23573057 |
| 31 | CAMKK2 | 1.22029723 |
| 32 | PNCK | 1.19399492 |
| 33 | PINK1 | 1.16941601 |
| 34 | TNIK | 1.16560716 |
| 35 | RET | 1.14910704 |
| 36 | PRKCG | 1.14644137 |
| 37 | SIK2 | 1.13606385 |
| 38 | NEK6 | 1.12976472 |
| 39 | SGK223 | 1.11848980 |
| 40 | SGK494 | 1.11848980 |
| 41 | PRKCH | 1.10322007 |
| 42 | FES | 1.09377215 |
| 43 | CDK19 | 1.08046838 |
| 44 | SGK2 | 1.07477532 |
| 45 | UHMK1 | 1.05540918 |
| 46 | PLK2 | 1.02243316 |
| 47 | MAPK13 | 1.00922776 |
| 48 | SGK3 | 1.00787521 |
| 49 | TTN | 0.97757134 |
| 50 | MAP3K1 | 0.96314851 |
| 51 | CAMK1 | 0.95973331 |
| 52 | CAMK2A | 0.95450047 |
| 53 | ARAF | 0.94301781 |
| 54 | TAOK1 | 0.87182893 |
| 55 | TYRO3 | 0.85932864 |
| 56 | STK11 | 0.84048980 |
| 57 | WNK1 | 0.83077627 |
| 58 | PAK3 | 0.82574997 |
| 59 | MAP3K13 | 0.81449093 |
| 60 | CAMK2B | 0.79873186 |
| 61 | AKT3 | 0.77803648 |
| 62 | RIPK1 | 0.76392111 |
| 63 | FER | 0.76238251 |
| 64 | INSRR | 0.75949358 |
| 65 | CAMK1G | 0.73395922 |
| 66 | CDC42BPA | 0.73132843 |
| 67 | SGK1 | 0.71873728 |
| 68 | PDK1 | 0.71646482 |
| 69 | OXSR1 | 0.70691029 |
| 70 | PDPK1 | 0.69705265 |
| 71 | LATS2 | 0.67376166 |
| 72 | TNK2 | 0.66533073 |
| 73 | MAPK10 | 0.66375707 |
| 74 | SCYL2 | 0.65917881 |
| 75 | CAMK2D | 0.65771852 |
| 76 | CDK15 | 0.64313506 |
| 77 | CDK18 | 0.64147357 |
| 78 | MAP3K7 | 0.63470155 |
| 79 | CDK14 | 0.62934560 |
| 80 | MAP2K1 | 0.59582914 |
| 81 | IRAK2 | 0.58730020 |
| 82 | CAMK2G | 0.58705228 |
| 83 | BRAF | 0.58426973 |
| 84 | ALK | 0.57561000 |
| 85 | PRKCE | 0.57514508 |
| 86 | PTK2B | 0.57319144 |
| 87 | WNK4 | 0.56204873 |
| 88 | MUSK | 0.55538335 |
| 89 | MARK2 | 0.54446091 |
| 90 | NME1 | 0.54427732 |
| 91 | FGFR2 | 0.53218907 |
| 92 | CDK11A | 0.52642352 |
| 93 | RPS6KA3 | 0.52603148 |
| 94 | WNK3 | 0.52421686 |
| 95 | MAPK7 | 0.50360288 |
| 96 | CSNK1G2 | 0.49912473 |
| 97 | DYRK1A | 0.49858421 |
| 98 | SIK3 | 0.49283370 |
| 99 | RAF1 | 0.48957300 |
| 100 | BMPR2 | 0.48529826 |
| 101 | SIK1 | 0.47981108 |
| 102 | JAK1 | 0.47681523 |
| 103 | DYRK1B | 0.46990720 |
| 104 | CAMK4 | 0.46227994 |
| 105 | NEK1 | 0.45864198 |
| 106 | TRIB3 | 0.45359480 |
| 107 | FYN | 0.45227952 |
| 108 | JAK2 | 0.44838029 |
| 109 | MAP3K11 | 0.44371563 |
| 110 | MOS | 0.44248902 |
| 111 | RPS6KA2 | 0.44018642 |
| 112 | PDGFRA | 0.42405454 |
| 113 | PKN1 | 0.42290740 |
| 114 | DMPK | 0.42009437 |
| 115 | PRKCZ | 0.41997452 |
| 116 | HIPK2 | 0.41778871 |
| 117 | ROCK2 | 0.40199195 |
| 118 | PDK3 | 0.39877345 |
| 119 | PDK4 | 0.39877345 |
| 120 | TAOK2 | 0.33902941 |
| 121 | PRKD1 | 0.32802503 |
| 122 | PRKG1 | 0.31643224 |
| 123 | PRKAA1 | 0.30843455 |
| 124 | LIMK1 | 0.30053383 |
| 125 | TESK1 | 0.29915091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.14859439 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.01206660 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.61246270 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51645056 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.51027531 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.44447661 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42863227 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.33856919 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 2.31359880 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.28593756 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26466439 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.25818313 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.03795271 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.02594044 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.90667533 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90300002 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84488239 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82627863 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69727409 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.66542093 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.58929218 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57310045 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55478631 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55299993 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52753497 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51432724 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.49846225 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.45947911 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43766680 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37247620 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35933040 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35613649 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23507755 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.23148115 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19417238 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18991592 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14011311 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11647582 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08976018 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06342824 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06260826 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.01789727 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01057599 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99174632 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 0.94395853 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93746393 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93121952 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92353140 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89351014 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86035673 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85078158 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82048940 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79113035 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 0.78324263 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.78083520 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77971559 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73561158 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71837243 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.67114524 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62833515 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62038521 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61973900 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61883047 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61118184 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61063244 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60149629 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59697782 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59403926 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59198067 |
| 70 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58469208 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58463651 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58379060 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56962230 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56565344 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56492842 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55984679 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54823734 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52269388 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50549421 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49389705 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48660804 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48236602 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47671941 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47172269 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47167752 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47075442 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47069552 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45773125 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.45152857 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44609069 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44608552 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44250424 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42427608 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.41878900 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41533562 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39276032 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38856943 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38688143 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38222874 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37957743 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37942751 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37197035 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36841748 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36546582 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35653642 |
| 106 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34932010 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.34433887 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.33466757 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32520487 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32460423 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31335249 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31255526 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.30288191 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28552576 |
| 115 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.28289458 |

